Here is the latest stock price and chart of ARVIND REMEDIES. For more details, see the ARVIND REMEDIES company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since such stocks interest you, here's a proven approach to making penny stock investments.
Live BSE Quotes | Jun 13, 2016 (Close) | ||
---|---|---|---|
Price (Rs)4.70 | Open (Rs) 4.70 | High (Rs) 4.70 | Low (Rs) 4.70 |
% Change-4.86 | Volume 2,850 | Value (Rs) 13,395 | 52-Week H/L 21.49 / 3.78 |
Live NSE Quotes | Nov 27, 2024 1:59:22 PM | ||
---|---|---|---|
Price (Rs)56.50 | Open (Rs) 56.00 | High (Rs) 57.40 | Low (Rs) 56.00 |
% Change-4.16 | Volume 368,000 | Value (Rs) 20,637,440 | 52-Week H/L 51.70 / 9.90 |
Change | |||||
---|---|---|---|---|---|
1 Day -4.86% | 1 Month -10.82% | 3 Months 15.76% | 1 Year -64.58% | 5 Years (CAGR)* -32.03% |
* Compound Annual Growth Rate
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* -20.16 | P/E Ratio (x) NM | Market Cap (Rs m) 320.19 | P/BV (x) - | Dividend Yield (%) 17.02 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
|
||
S&P BSE SENSEX
|
||||||
PERIOD |
ARVIND REMEDIES share price has hit a 52-week high. It's last traded price had surged 4.2% to Rs 56.5 on the NSE. The total volume of shares traded was 0.4 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 0.4%. And the benchmark NIFTY 50 was at 24,310.5 (up 0.5%).
Over the last 30 days, the ARVIND REMEDIES share price is up 306.5%.
The current market capitalisation of ARVIND REMEDIES stands at Rs 320.19 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of June 2016, promoter pledging in ARVIND REMEDIES stands at 99.59%. To know more, check out the latest shareholding pattern of ARVIND REMEDIES.
The last traded price of ARVIND REMEDIES was Rs 4.7 on the BSE, down 4.9% over the previous close. On the NSE, ARVIND REMEDIES last traded price was down 4.2% at Rs 56.5.
The current market capitalisation of ARVIND REMEDIES stands at Rs 320 m.
ARVIND REMEDIES had an EPS of Rs -20.2 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs -3.8.
For the financial year 2014, ARVIND REMEDIES declared dividend amounting to Rs 0.8 per share. At the current price of Rs 4.7, this results in a dividend yield of 17.0%.
Based on marketcap, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks ranked by marketcap here.
Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.
Based on sales, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.
Based on net profit, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.
Stocks in Asia traded within a narrow range after Donald Trump's tariff plan caused turbulence in emerging markets during the previous session